| Industry | 制造业 | ||||||||||||||||||||||||
| Company Introduction | 深圳市理邦精密仪器股份有限公司是一家医疗电子设备供应高新企业.公司主要产品为产科系列、监护系列、心电系列、超声影像系列四大类.公司是国家高新技术企业.根据国家食品药品监督管理局信息中心发布的《中国医疗诊断、监护及治疗设备制造行业发展分析》,2009年公司产科系列产品市场份额全国第一,心电系列产品国内品牌市场份额第一、出口市场份额第一,监护系列产品占出口市场份额第三.公司荣获福布斯杂志颁发的2009年度中国最具成长潜力200强企业(第17名)。 | ||||||||||||||||||||||||
| Main Business | 主要从事医疗电子设备产品和体外诊断产品的研发、生产、销售、服务 | ||||||||||||||||||||||||
| Legal Representative | 张浩 | ||||||||||||||||||||||||
| Top Executives |
|
||||||||||||||||||||||||
| Top 5 Shareholder |
|
||||||||||||||||||||||||
| Company Secretary | 祖幼冬 | ||||||||||||||||||||||||
| Solicitors | 北京市中伦律师事务所 | ||||||||||||||||||||||||
| Auditors | 信永中和会计师事务所有限责任公司 | ||||||||||||||||||||||||
| Tel No | 0755-26851437 | ||||||||||||||||||||||||
| Fax No | 0755-26850550 | ||||||||||||||||||||||||
| Website | www.edan.com | ||||||||||||||||||||||||
| IR@edan.com | |||||||||||||||||||||||||
| Company Address |
|
||||||||||||||||||||||||
| Listing Date | 21/04/2011 | ||||||||||||||||||||||||
| Shares Capital |
|
||||||||||||||||||||||||
| EPS(RMB)* | ¥ 0.382 | ||||||||||||||||||||||||
| DPS(RMB)* | ¥ 0.207 | ||||||||||||||||||||||||
| NBV Per Share(RMB)* | ¥ 3.378 | ||||||||||||||||||||||||
| Market Capitalization(RMB) | 3.105B |
 |
Only Chinese content is avaliable |
|
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
| * | Unadjusted Data |
| Information provided by: etnet | ||
| Terms and Conditions | ||
| Risk Disclosure: |
| The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
| Disclaimer: |
| This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources, Nanyang Commercial Bank Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |